Published in J Bone Joint Surg Br on November 01, 2003
The central role of wear debris in periprosthetic osteolysis. HSS J (2006) 1.85
The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses. J R Soc Interface (2008) 1.32
The basic science of periprosthetic osteolysis. Instr Course Lect (2001) 1.18
The basic science of periprosthetic osteolysis. Instr Course Lect (2013) 0.93
Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement. Acta Biomater (2014) 0.92
Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact. Mol Cancer (2009) 0.85
Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome. Biomed Res Int (2013) 0.85
Polymethylmethacrylate particles stimulate bone resorption of mature osteoclasts in vitro. Acta Orthop (2008) 0.82
Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK. BMC Musculoskelet Disord (2006) 0.81
Interaction of Materials and Biology in Total Joint Replacement - Successes, Challenges and Future Directions. J Mater Chem B Mater Biol Med (2014) 0.79
Genetic susceptibility to hip arthroplasty failure--association with the RANK/OPG pathway. Int Orthop (2006) 0.79
Titanium particles stimulate COX-2 expression in synovial fibroblasts through an oxidative stress-induced, calpain-dependent, NF-kappaB pathway. Am J Physiol Cell Physiol (2009) 0.79
On the inflammatory response in metal-on-metal implants. J Transl Med (2014) 0.78
Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro. J Mater Sci Mater Med (2009) 0.78
Evaluation of trabecular bone formation in a canine model surrounding a dental implant fixture immobilized with an antimicrobial peptide derived from histatin. J Mater Sci Mater Med (2011) 0.78
Effects of Ti, PMMA, UHMWPE, and Co-Cr wear particles on differentiation and functions of bone marrow stromal cells. J Biomed Mater Res A (2013) 0.78
Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. Inflammation (2012) 0.78
BMPs in periprosthetic tissues around aseptically loosened total hip implants. Acta Orthop (2010) 0.75
Alteration of the RANKL/RANK/OPG System in Periprosthetic Osteolysis with Septic Loosening. Inflammation (2016) 0.75
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Failure of reduction with an external fixator in the management of injuries of the pelvic ring. Long-term evaluation of 110 patients. J Bone Joint Surg Br (1999) 2.41
Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol (1999) 2.34
Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis (1999) 2.06
Does arthroscopic acromioplasty provide any additional value in the treatment of shoulder impingement syndrome?: a two-year randomised controlled trial. J Bone Joint Surg Br (2009) 2.03
Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest (1998) 1.97
Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg (2004) 1.89
Regulation of macrophage activation. Cell Mol Life Sci (2003) 1.83
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem (1997) 1.82
Factors associated with nonunion in conservatively-treated type-II fractures of the odontoid process. J Bone Joint Surg Br (2004) 1.80
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer (1996) 1.71
Acute soccer injuries in Finland in 1980. Br J Sports Med (1985) 1.71
Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers. Clin Cancer Res (2000) 1.60
Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum (1997) 1.58
Vitamins A and E, retinol binding protein and zinc in rheumatoid arthritis. Clin Exp Rheumatol (1990) 1.57
The results of operative resection of the lateral end of the clavicle. J Bone Joint Surg Am (1996) 1.52
Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol (1996) 1.52
Abdominal injuries sustained in severe traffic accidents by seatbelt wearers. J Trauma (1987) 1.50
Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol (1996) 1.49
Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun (1992) 1.45
Bone regeneration and stem cells. J Cell Mol Med (2011) 1.41
Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses. Antimicrob Agents Chemother (1996) 1.40
Removal of hyaline articular cartilage reduces lymphocyte infiltration and activation in rheumatoid synovial membrane. J Rheumatol (2001) 1.39
Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia (2008) 1.37
Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol (1995) 1.35
Outcome of sports injuries treated in a casualty department. Br J Sports Med (1985) 1.35
Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg Am (1990) 1.34
Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum (2000) 1.31
Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis. Ann Rheum Dis (1985) 1.30
Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol (1988) 1.29
MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis (2005) 1.27
Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis (2003) 1.26
Aggressive granulomatous lesions in cementless total hip arthroplasty. J Bone Joint Surg Br (1990) 1.24
Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob Agents Chemother (1992) 1.23
Incidence of pelvic fractures in Finland in 1988. Acta Orthop Scand (1995) 1.23
MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res (2007) 1.21
MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.19
Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study. Br J Rheumatol (1998) 1.19
Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19
Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol (2008) 1.18
Characterization of the immunocompetent cells of rheumatoid synovium from tissue sections and eluates. Arthritis Rheum (1981) 1.17
Evaluation of patients with rheumatoid cervical spine. Scand J Rheumatol (1987) 1.16
Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1beta. Clin Exp Rheumatol (2005) 1.15
Osteolysis around total knee arthroplasty: a review of pathogenetic mechanisms. Acta Biomater (2013) 1.15
The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis. Arthritis Rheum (1992) 1.13
Maxillofacial fractures sustained in bicycle accidents. Int J Oral Maxillofac Surg (1986) 1.13
Intravascular synovial sarcoma. Hum Pathol (1987) 1.12
A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels. Matrix Biol (1998) 1.12
Cementless total replacement for old tuberculosis of the hip. J Bone Joint Surg Br (1988) 1.10
Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage. Brain (2001) 1.10
Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience (1993) 1.09
Fibroblast biology. Signals targeting the synovial fibroblast in arthritis. Arthritis Res (2000) 1.09
Occipital headache in rheumatoid cervical facet joint arthritis. Lancet (1986) 1.08
New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol (1998) 1.08
DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study. J Rheumatol (1989) 1.08
Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest (1995) 1.07
Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow up study. Br Med J (Clin Res Ed) (1988) 1.06
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices. Blood (2001) 1.06
Cell-mediated immune response in the diseased joints in patients with reactive arthritis. Scand J Immunol (1986) 1.06
Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum (1994) 1.06
Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci (1994) 1.06
MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci (1999) 1.05
Mast cell-derived tryptase in odontogenic cysts. J Oral Pathol Med (1996) 1.05
The 3D topography of MEG source localization accuracy: effects of conductor model and noise. Clin Neurophysiol (2003) 1.05
Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol (1996) 1.05
Immune response to polyglycolic acid implants. J Bone Joint Surg Br (1990) 1.05
Membrane components of Treponema denticola trigger proteinase release from human polymorphonuclear leukocytes. J Dent Res (1996) 1.04
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer (2006) 1.03
Lymphocyte infiltrations of the gastric mucosa in Sjögren's syndrome. An immunoperoxidase study using monoclonal antibodies in the avidin-biotin-peroxidase method. Arthritis Rheum (1983) 1.03
No evidence of long-term benefits of arthroscopicacromioplasty in the treatment of shoulder impingement syndrome: Five-year results of a randomised controlled trial. Bone Joint Res (2013) 1.03
Inflammatory involvement of cervical spine ligaments in patients with rheumatoid arthritis and atlantoaxial subluxation. J Rheumatol (1987) 1.03
Acid attack and cathepsin K in bone resorption around total hip replacement prosthesis. J Bone Miner Res (2001) 1.03
Chest injuries sustained in severe traffic accidents by seatbelt wearers. J Trauma (1989) 1.03
Disc degeneration and angular movement of the lumbar spine: comparative study using plain and flexion-extension radiography and discography. J Spinal Disord (1991) 1.02
Fractures of the talus. J Trauma (1984) 1.02
Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res (1996) 1.02
Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases. Biochem Biophys Res Commun (1990) 1.02
Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article. J Periodontol (1993) 1.01
Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement. J R Soc Interface (2014) 1.01
Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob Agents Chemother (1993) 1.01
Tumor necrosis factor-alpha (TNF-alpha) in loosening of total hip replacement (THR). Clin Exp Rheumatol (1997) 1.00
Cellular source, activation and inhibition of dental plaque collagenase. J Clin Periodontol (1995) 1.00